These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34765046)

  • 21. Altered Electrical, Biomolecular, and Immunologic Phenotypes in a Novel Patient-Derived Stem Cell Model of Desmoglein-2 Mutant ARVC.
    Hawthorne RN; Blazeski A; Lowenthal J; Kannan S; Teuben R; DiSilvestre D; Morrissette-McAlmon J; Saffitz JE; Boheler KR; James CA; Chelko SP; Tomaselli G; Tung L
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arrhythmogenic Right Ventricular Cardiomyopathy Accompanied by Chronic Myocarditis.
    Nakamura M; Imamura T; Fukui T; Kataoka N; Kinugawa K
    Intern Med; 2022 Oct; 61(20):3063-3067. PubMed ID: 35342132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PKP2 mutations in sudden death from arrhythmogenic right ventricular cardiomyopathy (ARVC) and sudden unexpected death with negative autopsy (SUDNA).
    Zhang M; Tavora F; Oliveira JB; Li L; Franco M; Fowler D; Zhao Z; Burke A
    Circ J; 2012; 76(1):189-94. PubMed ID: 22019812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arrhythmogenic right ventricular cardiomyopathy: new insights into disease mechanisms and diagnosis.
    Saffitz JE; Asimaki A; Huang H
    J Investig Med; 2009 Dec; 57(8):861-4. PubMed ID: 19952894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arrhythmogenic cardiomyopathy and abnormalities of cell-to-cell coupling.
    Saffitz JE
    Heart Rhythm; 2009 Aug; 6(8 Suppl):S62-5. PubMed ID: 19541548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of {beta}-catenin signaling.
    Li J; Swope D; Raess N; Cheng L; Muller EJ; Radice GL
    Mol Cell Biol; 2011 Mar; 31(6):1134-44. PubMed ID: 21245375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Desmosomal COP9 regulates proteome degradation in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Liang Y; Lyon RC; Pellman J; Bradford WH; Lange S; Bogomolovas J; Dalton ND; Gu Y; Bobar M; Lee MH; Iwakuma T; Nigam V; Asimaki A; Scheinman M; Peterson KL; Sheikh F
    J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 33857019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in the area composita protein αT-catenin are associated with arrhythmogenic right ventricular cardiomyopathy.
    van Hengel J; Calore M; Bauce B; Dazzo E; Mazzotti E; De Bortoli M; Lorenzon A; Li Mura IE; Beffagna G; Rigato I; Vleeschouwers M; Tyberghein K; Hulpiau P; van Hamme E; Zaglia T; Corrado D; Basso C; Thiene G; Daliento L; Nava A; van Roy F; Rampazzo A
    Eur Heart J; 2013 Jan; 34(3):201-10. PubMed ID: 23136403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin.
    La Gerche A; Robberecht C; Kuiperi C; Nuyens D; Willems R; de Ravel T; Matthijs G; Heidbüchel H
    Heart; 2010 Aug; 96(16):1268-74. PubMed ID: 20525856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update.
    Azaouagh A; Churzidse S; Konorza T; Erbel R
    Clin Res Cardiol; 2011 May; 100(5):383-94. PubMed ID: 21360243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population-prevalent desmosomal mutations predisposing to arrhythmogenic right ventricular cardiomyopathy.
    Lahtinen AM; Lehtonen E; Marjamaa A; Kaartinen M; Heliö T; Porthan K; Oikarinen L; Toivonen L; Swan H; Jula A; Peltonen L; Palotie A; Salomaa V; Kontula K
    Heart Rhythm; 2011 Aug; 8(8):1214-21. PubMed ID: 21397041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial expression profiles of candidate molecules in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia compared to those with dilated cardiomyopathy and healthy controls.
    Akdis D; Medeiros-Domingo A; Gaertner-Rommel A; Kast JI; Enseleit F; Bode P; Klingel K; Kandolf R; Renois F; Andreoletti L; Akdis CA; Milting H; Lüscher TF; Brunckhorst C; Saguner AM; Duru F
    Heart Rhythm; 2016 Mar; 13(3):731-41. PubMed ID: 26569459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monozygotic twins with myocarditis and a novel likely pathogenic desmoplakin gene variant.
    Kissopoulou A; Fernlund E; Holmgren C; Isaksson E; Karlsson JE; Green H; Jonasson J; Ellegård R; Årstrand HK; Svensson A; Gunnarsson C
    ESC Heart Fail; 2020 Jun; 7(3):1210-1216. PubMed ID: 32301586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular genetics of arrhythmogenic right ventricular cardiomyopathy: emerging horizon?
    van Tintelen JP; Hofstra RM; Wiesfeld AC; van den Berg MP; Hauer RN; Jongbloed JD
    Curr Opin Cardiol; 2007 May; 22(3):185-92. PubMed ID: 17413274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy.
    Syrris P; Ward D; Asimaki A; Sen-Chowdhry S; Ebrahim HY; Evans A; Hitomi N; Norman M; Pantazis A; Shaw AL; Elliott PM; McKenna WJ
    Circulation; 2006 Jan; 113(3):356-64. PubMed ID: 16415378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and significance of rare RYR2 variants in arrhythmogenic right ventricular cardiomyopathy/dysplasia: results of a systematic screening.
    Roux-Buisson N; Gandjbakhch E; Donal E; Probst V; Deharo JC; Chevalier P; Klug D; Mansencal N; Delacretaz E; Cosnay P; Scanu P; Extramiana F; Keller D; Hidden-Lucet F; Trapani J; Fouret P; Frank R; Fressart V; Fauré J; Lunardi J; Charron P
    Heart Rhythm; 2014 Nov; 11(11):1999-2009. PubMed ID: 25041964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy.
    Rigato I; Bauce B; Rampazzo A; Zorzi A; Pilichou K; Mazzotti E; Migliore F; Marra MP; Lorenzon A; De Bortoli M; Calore M; Nava A; Daliento L; Gregori D; Iliceto S; Thiene G; Basso C; Corrado D
    Circ Cardiovasc Genet; 2013 Dec; 6(6):533-42. PubMed ID: 24070718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular insights into arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 missense mutations.
    Kirchner F; Schuetz A; Boldt LH; Martens K; Dittmar G; Haverkamp W; Thierfelder L; Heinemann U; Gerull B
    Circ Cardiovasc Genet; 2012 Aug; 5(4):400-11. PubMed ID: 22781308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: an update.
    Calkins H; Marcus F
    Curr Cardiol Rep; 2008 Sep; 10(5):367-75. PubMed ID: 18715533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arrhythmogenic right ventricular cardiomyopathy plakophilin-2 mutations disrupt desmosome assembly and stability.
    Hall C; Li S; Li H; Creason V; Wahl JK
    Cell Commun Adhes; 2009; 16(1-3):15-27. PubMed ID: 19533476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.